$11.62
$11.37
$14.52
$9.04
$3.4B
4.96%
This is a preview of the full version of Prosperse
Amicus Therapeutics, a global biotechnology company focused on rare diseases, announced that it will participate in upcoming investor conferences in September 2024.
N/A
Aug 30, 2024
Amicus Therapeutics reported strong Q2 2024 results, with revenue up 34% year-over-year and EPS beating estimates. The company's key metrics, including geographic revenues and net product revenues, also showed solid performance.
Zacks.Com
Aug 9, 2024
Date: Oct 25, 2024
Date: Oct 25, 2024
Date: Oct 25, 2024
Date: Oct 24, 2024
Date: Oct 24, 2024